Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) Foundation Study
ISRCTN ISRCTN25675619
ClinicalTrials.gov identifier
Public title DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) Foundation Study
Scientific title A randomised controlled trial of the DESMOND Foundation Programme for people with established Type 2 diabetes in a multi-ethnic population in Leicester and South Birmingham
Acronym N/A
Serial number at source 1
Study hypothesis The main aim of the study is to test the hypothesis that a structured education module in diabetes with proven effectiveness in a white, newly diagnosed population can be modified for use in a multi-ethnic population with established diabetes (>=12 months < 10 years duration), to improve biomedical, lifestyle and psychological patient outcomes 6 and 12 months post intervention.
Lay summary
Ethics approval Leicestershire, Northamptonshire & Rutland Research Ethics Committee 1 approved on the 25th February 2010 (ref: 09/H0406/116)
Study design Multi centre cluster randomised controlled trial with randomisation at practice level.
Countries of recruitment United Kingdom
Disease/condition/study domain Established Type 2 diabetes mellitus (≥ 12 months < 10 years duration)
Participants - inclusion criteria 1. Patients have established Type 2 diabetes of a duration ≥ 12 months < 10 years duration
2. Not receiving insulin therapy
3. Controlling their diabetes by diet or any combination of OHAs (oral hypoglycaemic agents)
4. HbA1c ≥ 7.0% and ≤ 10.0%
5. Able to participate in a group programme
6. Age ≥ 18 and < 75 years of age
7. South Asian patients whose first language is not English, will need to be Gujarati speaking (Leicester) or Urdu or Punjabi speaking (South Birmingham)
Participants - exclusion criteria 1. Patients who have already attended a DESMOND programme
2. Unable to give informed consent
3. Severe and enduring mental health problems e.g. diagnosed with psychotic illness
4. Patient not primarily responsible for their own care
5. Unable to participate in a group programme (e.g. housebound)
6. Do not have Type 2 diabetes
7. Newly diagnosed with Type 2 diabetes (< 12 months)
8. Currently taking part in a research study
9. Receiving insulin therapy
Anticipated start date 01/07/2010
Anticipated end date 01/12/2012
Status of trial Ongoing
Patient information material Not available in web format. Please use contact details below to request a patient information leaflet
Target number of participants 640
Interventions The DESMOND structured group education programme for patients with established Type 2 diabetes. When delivered in English this a 6 hour programme (two sessions of 3 hours each) or when delivered in Gujarati, Urdu or Punjabi a 12 hour programme (4 sessions of 3 hours each) with an interpreter present.
Primary outcome measure(s) HbA1c measured at 6 and 12 month follow up
Secondary outcome measure(s) Measures at 6 and 12 month follow up:
1. Blood cholesterol
2. Body weight
3. Blood pressure
4. Waist and hip circumference
5. Lifestyle (smoking and physical activity)
6. Questionnaire tools listed below:
6.1 Illness Perception Questionnaire Revised (IPQ-R)
6.2 Diabetes Illness Representations Questionnaire (DIRQ)
6.3 The Hospital Anxiety & Depression Scale (HADS)
6.4 International Physical Activity Questionnaire (IPAQ)
6.5 Problem Areas in Diabetes Scales (PAIDS)
6.3 International Physical Activity Questionnaire (IPAQ)
Sources of funding National Institute for Health Research (NIHR) (UK) - Collaboration for Leadership in Applied Health Research and Care (CLAHRC)
Trial website
Publications
Contact name Prof  Melanie  Davies
  Address Diabetes Research
Victoria Building
Leicester Royal Infirmary
  City/town Leicester
  Zip/Postcode LE1 5WW
  Country United Kingdom
  Email melanie.davies@uhl-tr.nhs.uk
Sponsor University Hospital of Leicester (UK)
  Address Gwendolen Road
  City/town Leicester
  Zip/Postcode LE5 4PW
  Country United Kingdom
  Email carolyn.maloney@uhl-tr.nhs.uk
  Sponsor website: http://www.uhl-tr.nhs.uk
Date applied 03/06/2010
Last edited 29/07/2010
Date ISRCTN assigned 29/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central